Nightingale Health Oyj
OMXH:HEALTH
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.994
4.11
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HEALTH stock under the Base Case scenario is 0.98 EUR. Compared to the current market price of 2.76 EUR, Nightingale Health Oyj is Overvalued by 65%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Nightingale Health Oyj
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HEALTH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Nightingale Health Oyj
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Nightingale Health Oyj
Balance Sheet Decomposition
Nightingale Health Oyj
Current Assets | 68.4m |
Cash & Short-Term Investments | 66m |
Receivables | 1.7m |
Other Current Assets | 704k |
Non-Current Assets | 22.4m |
Long-Term Investments | 37k |
PP&E | 8.6m |
Intangibles | 13.3m |
Other Non-Current Assets | 439k |
Current Liabilities | 7m |
Accounts Payable | 4.3m |
Other Current Liabilities | 2.7m |
Non-Current Liabilities | 1m |
Long-Term Debt | 985k |
Other Non-Current Liabilities | 23k |
Earnings Waterfall
Nightingale Health Oyj
Revenue
|
4.4m
EUR
|
Cost of Revenue
|
-1.5m
EUR
|
Gross Profit
|
2.9m
EUR
|
Operating Expenses
|
-21.5m
EUR
|
Operating Income
|
-18.6m
EUR
|
Other Expenses
|
1.1m
EUR
|
Net Income
|
-17.5m
EUR
|
Free Cash Flow Analysis
Nightingale Health Oyj
EUR | |
Free Cash Flow | EUR |
Nightingale Health continues to display steady financial improvements and strategic growth. The company reported a 4% year-over-year increase in full-year revenue to EUR 4.358 million, marking its highest revenue to date. Despite a net loss of EUR 17.46 million, Nightingale maintains robust financial health with EUR 63 million in net cash and no debt on its balance sheet. The company emphasizes a shift towards more stable healthcare revenue, boosted by new deals such as the Terveystalo Occupational Health agreement. With multiple international deals in progress, Nightingale forecasts becoming EBITDA positive in the midterm and aims for significant international expansion.
What is Earnings Call?
HEALTH Profitability Score
Profitability Due Diligence
Nightingale Health Oyj's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Nightingale Health Oyj's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
HEALTH Solvency Score
Solvency Due Diligence
Nightingale Health Oyj's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Nightingale Health Oyj's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HEALTH Price Targets Summary
Nightingale Health Oyj
According to Wall Street analysts, the average 1-year price target for HEALTH is 1.99 EUR with a low forecast of 1.01 EUR and a high forecast of 3.05 EUR.
Dividends
Current shareholder yield for HEALTH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. The company is headquartered in Helsinki, Etela-Suomen and currently employs 77 full-time employees. The company went IPO on 2021-03-19. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The firm provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Company’s subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The firm owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.
Contact
IPO
Employees
Officers
The intrinsic value of one HEALTH stock under the Base Case scenario is 0.98 EUR.
Compared to the current market price of 2.76 EUR, Nightingale Health Oyj is Overvalued by 65%.